Journal article
Process evaluation of a data-driven quality improvement program within a cluster randomised controlled trial to improve coronary heart disease management in Australian primary care
N Hafiz, K Hyun, Q Tu, A Knight, C Hespe, CK Chow, T Briffa, R Gallagher, CM Reid, DL Hare, N Zwar, M Woodward, S Jan, ER Atkins, TL Laba, E Halcomb, T Johnson, D Manandi, T Usherwood, J Redfern
Plos One | PUBLIC LIBRARY SCIENCE | Published : 2024
Abstract
Background This study evaluates primary care practices' engagement with various features of a quality improvement (QI) intervention for patients with coronary heart disease (CHD) in four Australian states. Methods Twenty-seven practices participated in the QI intervention from November 2019 -November 2020. A combination of surveys, semi-structured interviews and other materials within the QUality improvement in primary care to prevent hospitalisations and improve Effectiveness and efficiency of care for people Living with heart disease (QUEL) study were used in the process evaluation. Data were summarised using descriptive statistical and thematic analyses for 26 practices. Results Sixty-fou..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The authors acknowledge the support of all the PHN and primary care practices who continue to support the QUEL project. Also, PenCS for providing the services and eHealth data platform for the study; and the Improvement Foundation for their continuous support in the delivery of the QI program and other study partners including; Inala Primary Care, Fairfield Hospital General Practice Unit, Australian Primary Health Care Nurses Association, Royal Australian College of General Practitioners, Australian Commission on Safety and Quality in Health Care, Heart Support Australia Ltd, Austin Health, Australian Cardiovascular Health and Rehabilitation Association, National Heart Foundation, Sanofi, and Amgen. The authors would also like to acknowledge the ongoing contribution of Kane Williams in the legal arrangement and Caroline Wu in the research management of the trial.